• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS HBSAG CONFIRMATORY TEST; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS HBSAG CONFIRMATORY TEST; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 11820648122
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/31/2022
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.
 
Event Description
There was an allegation of questionable elecsys hbsag confirmatory test results for 4 patient samples on a cobas e 801 analytical unit.The customer suspects that the hbsag confirmatory results are false positive in relation to the anti-hepatitis b surface antibody and anti-hepatitis b core antibody results.They were questioning whether this pattern of results was possible.On (b)(6) 2022, patient b's sample was tested on line c and had two reactive hbsag test results.The first result was 2.04 coi and the second result after re-centrifugation was 1.82 coi.The hbsag confirmatory test was performed and the result was reactive with a quantitative result of 0.436.The anti-hepatitis b surface antibody result was non-reactive with a quantitative result of <2 miu/ml.The anti-hepatitis b core antibody result was non-reactive with a quantitative result of 2.02 coi.Patient c's sample was tested on line c and had three reactive hbsag test results.The first result was 1.5 coi, the second result was 1.56 coi, and the third result after re-centrifugation was 1.5 coi.The hbsag confirmatory test was performed and the result was reactive with a quantitative result of 0.474.The anti-hepatitis b surface antibody result was non-reactive with a quantitative result of 8 miu/ml.The anti-hepatitis b core antibody result was non-reactive with a quantitative result of 2.06 coi.Patient d's sample was tested on line c and had three reactive hbsag test results.The first result was 2 coi, the second result was 2.03 coi, and the third result after re-centrifugation was 1.97 coi.The hbsag confirmatory test was performed and the result was reactive with a quantitative result of 0.42.The anti-hepatitis b surface antibody result was non-reactive with a quantitative result of 4 miu/ml.The anti-hepatitis b core antibody result was non-reactive with a quantitative result of 2.23 coi.On (b)(6) 2023, patient e's sample was tested on group line 1 and had two reactive hbsag test results.The first result was 1.16 coi and the second result was 1.21 coi.The hbsag confirmatory test was performed and the result was reactive with a quantitative result of 0.418.The anti-hepatitis b surface antibody result was non-reactive with a quantitative result of <2 miu/ml.The anti-hepatitis b core antibody result was non-reactive with a quantitative result of 2.20 coi.The hbsag confirmatory units of measure were requested but not provided.No questionable results were reported outside of the laboratory.The analyzer serial number is (b)(4).
 
Manufacturer Narrative
Based on the calibration and qc data provided, a general reagent issue could be excluded.It was determined that the root cause of the event is consistent with contamination and pre-analytical sample handling issues.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS HBSAG CONFIRMATORY TEST
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16285810
MDR Text Key308761260
Report Number1823260-2023-00326
Device Sequence Number1
Product Code LOM
UDI-Device Identifier04015630911110
UDI-Public04015630911110
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
P990012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Catalogue Number11820648122
Device Lot Number644791
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/07/2023
Initial Date FDA Received02/02/2023
Supplement Dates Manufacturer Received03/14/2023
Supplement Dates FDA Received04/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age23 YR
Patient SexMale
-
-